RT-PCR for Mammaglobin Genes, MGB1 and MGB2, Identifies Breast Cancer Micrometastases in Sentinel Lymph Nodes

American Journal of Clinical Pathology

Volumn 121, Issue 5, 2004, Pages 637-643

  Ouellette, Rodney J ^a,b   Richard, Dominique ^a   Maïcas, Emmanuel ^c  

^a Beausejour Medical Research Institute   (Canada)

^b UNIVERSITÉ DE MONCTON   (Canada)

^c Dr Georges L Dumont Regional Hospital   (Canada)

Author keywords

Breast carcinoma; MGB1; MGB2; Reverse transcription polymerase chain reaction; RT PCR; Sentinel lymph node; SLN

Indexed keywords

COMPLEMENTARY DNA; MAMMAGLOBIN; MESSENGER RNA;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; METASTASIS; MGB1 GENE; MGB2 GENE; ONCOGENE NEU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE;

EID: 2042498844     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/MMACTXT55L8QTKC1     Document Type: Article

References (45)

1. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;17:392-399.
2. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg. 1995;130:654-658.
3. Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol. 1993;2:335-339.
4. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Arch Surg. 1994;220:391-398.
5. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222:394-399.
6. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818-1822.
7. Nwariaku FE, Euhus DM, Beitsch PD, et al. Sentinel lymph node biopsy, an alternative to elective axillary dissection for breast cancer. Am J Surg. 1998;176:529-531.
8. Kissin MW, Querci della Rovere G, Easton D, et al. Risk of lymphoedema following the treatment of breast cancer. Br J Surg. 1986;73:580-584.
9. Bryant M, Baum M. Postoperative seroma following mastectomy and axillary dissection. Br J Surg. 1987;74:1187.
10. Ivens D, Hoe AL, Podd TJ, et al. Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992;66:136-138.
11. Keramopoulos A, Tsionou C, Minaretzis D, et al. Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology. 1993;50:445-449.
12. Friedman S, Bertin F, Mouriesse H, et al. Importance of tumor cells in axillary node sinus margins ("clandestine" metastasis) discovered by serial sectioning in operable breast carcinoma. Acta Oncol. 1988;27:483-487.
13. Bettelheim R, Price KN, Gelber RD, et al. The International Breast Cancer Study Group (Ludwig Trial): prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-1568.
14. Trojani M, de Mascarel I, Bonichon F, et al. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987;55:303-306.
15. Hainsworth PJ, Tjandra JJ, Stillwell RG, et al. Detection and significance of occult metastases in node-negative breast cancer. Br J Surg. 1993;80:459-463.
16. Coté RJ, Peterson HF, Chaiwun B, et al. The International Breast Cancer Study Group: role of immunohistochemical detection of lymph-node metastases in management of breast cancer. Lancet. 1999;354:896-900.
17. Schreiber RH, Pendas S, Ku NN, et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann Surg Oncol. 1999;6:95-101.
18. Jakub JW, Diaz NM, Ebert MD, et al. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg. 2002;184:302-306.
19. Motomura K, Komoike Y, Inaji H, et al. Multiple sectioning and immunohistochemical staining of sentinel nodes in patients with breast cancer. Br J Surg. 2002;89:1032-1034.
20. Fisher ER, Swonidoss S, Lee CH, et al. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 1978;45:2025-2031.
21. Gardner B, Feldman J. Are positive axillary nodes in breast cancer markers for incurable disease? Ann Surg. 1993;218:270-278.
22. Hellman S. Natural history of small breast cancers. J Clin Oncol. 1994;12:2229-2234.
23. Noguchi S, Aihara T, Nakamori S, et al. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer. 1994;74:1595-1600.
24. Schoenfeld A, Luqmani Y, Smith D, et al. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res. 1994;54:2986-2990.
25. Bostick PJ, Chatterjee S, Chi DD, et al. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol. 1998;16:2632-2640.
26. Burchill SA, Bradbury MF, Pittman K, et al. Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer. 1995;71:278-281.
27. Trudeau WL, Fields KK, Sullivan DM, et al. Detection of cytokeratin 19 (CK19) transcript in the lymph nodes (LN) of patients with breast cancer by RT-PCR [abstract]. Proc Am Assoc Cancer Res. 1998;39:511.
28. Ooka M, Sakita I, Fujiwara Y, et al. Selection of mRNA markers for detection of lymph node micrometastases in breast cancer patients. Oncol Rep. 2000;7:561-566.
29. Watson MA, Fleming TP. Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res. 1996;56:860-865.
30. Watson MA, Darrow C, Zimonjic DB, et al. Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene. 1998;16:817-824.
31. Becker RM, Darrow C, Zimonjic DB, et al. Identification of mammaglobin B, a novel member of the uteroglobin gene family. Genomics. 1998;54:70-78.
32. Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res. 1999;59:3028-3031.
33. Min CJ, Tafra L, Verbanac KM. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res. 1998;58:4581-4584.
34. Leygue E, Snell L, Dotzlaw H, et al. Mammaglobin, a potential marker of breast cancer nodal metastasis. J Pathol. 1999;189:28-33.
35. Corradini P, Voena C, Astolfi M, et al. Maspin and mammaglobin genes are specific markers for RT-PCR detection of minimal residual disease in patients with breast cancer. Ann Oncol. 2001;12:1693-1698.
36. Aihara T, Fujiwara Y, Ooka M, et al. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction. Breast Cancer Res Treat. 1999;58:137-140.
37. Kataoka A, Mori M, Sadanaga N, et al. RT-PCR detection of breast cancer cells in sentinel lymph modes. Int J Oncol. 2000;16:1147-1152.
38. Manzotti M, Dell'Oro S, Maisonneuve P, et al. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int J Cancer. 2001;95:307-312.
39. Zehentner BK, Dillon DC, Jiang Y, et al. Application of a multigene reverse transcription-PCR assay for detection of mammaglobin and complementary transcribed genes in breast cancer lymph nodes. Clin Chem. 2002;48:1225-1231.
40. Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628-3636.
41. Miltenburg DM, Miller C, Karamlou TB, et al. Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res. 1999;84:138-142.
42. Branagan G, Hughes D, Jeffrey M, et al. Detection of micrometastases in lymph nodes from patients with breast cancer. Br J Surg. 2002;89:86-89.
43. Fleming TP, Watson MA. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann N Y Acad Sci. 2000;923:78-89.
44. Gal S, Fidler C, Lo YM, et al. Detection of mammaglobin mRNA in the plasma of breast cancer patients. Ann N Y Acad Sci. 2001;945:192-194.
45. Zach O, Wagner H, Kasparu H, et al. Statistical validation of the mammaglobin-nested RT-PCR assay for tumor cell detection in blood of breast cancer patients. Biotechniques. 2001;31:1358-1362.